Clinical trial
Technology-supported, Meal-centric, Insulin Dosing for Optimized Post-prandial Glucose Control
NCT03758430 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Technology-supported, Meal-centric, Insulin Dosing for Optimized Post-prandial Glucose Control
- Lead sponsor
- Eli Lilly and Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 6, 2019
- Completion date
- August 7, 2020
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.